|
|
||||||||
1 Department of Radiology, Royal Brompton Hospital, London SW3 6NP; 2 Department of Respiratory Medicine, Green Lane Hospital, Auckland, New Zealand; and 3 Clinical Studies Unit, National Heart and Lung Institute, London SW3 6LY, United Kingdom
| |
ABSTRACT |
|---|
|
|
|---|
The purpose of this study was to investigate whether hypoxic pulmonary vasoconstriction is the major determinant of the computed tomography (CT) pattern of mosaic attenuation in asthmatic patients with induced bronchoconstriction. Thin-section CT was performed at suspended full inspiration immediately and 30 min after methacholine bronchoprovocation in 22 asthmatic subjects, who were randomly assigned to breathe room air (group A, n = 8), oxygen via nasal prongs at 5 l/min (group B, n = 8), and oxygen via face mask at 12 l/min (group C, n = 6). CT changes were quantified in terms of global lung density and density in hypodense and hyperdense areas. Lung parenchymal density increases were greatest in group C and greater in group B than in group A, globally (P = 0.03) and in hypodense regions (P = 0.01). On bivariate analysis, the only change in cross-sectional area was related to change in global density. In hypodense regions, density change was related both to reduction in cross-sectional area (P < 0.0005) and to oxygen administration (P = 0.01). After correction for changes in global lung density, only oxygen was independently related to density increase in hypodense areas (P = 0.02). In induced bronchoconstriction, the CT appearance of mosaic attenuation can be largely ascribed to hypoxic vasoconstriction rather than to changes in lung inflation.
hypoxic pulmonary vasoconstriction; computed tomography of the lung; functional computed tomography
| |
INTRODUCTION |
|---|
|
|
|---|
REGIONAL INHOMOGENEITY of the density of the lung parenchyma on high-resolution computed tomography (CT) has been described as a mosaic pattern (36). The mosaic pattern of lung attenuation on high-resolution CT has recently been documented in pulmonary vascular disease (1, 21, 33, 43) and may also be prominent in obstructive airway disease, especially in acute asthma (26), constrictive obliterative bronchiolitis (16), and bronchiectasis (14). In pulmonary vascular disease, such as chronic pulmonary embolism or primary pulmonary arterial hypertension, the term "mosaic perfusion" is appropriate because a vasculopathy is the underlying cause of the high-resolution CT pattern (1, 21, 33, 43). However, in obstructive airway disease there are three components that determine lung density: lung tissue, blood vessels, and air. On expiratory images, the mosaic pattern of lung attenuation caused by airway obstruction is accentuated, but areas of decreased attenuation frequently are also detectable on images obtained in full suspended inspiration (36). Regional overinflation and hypoxic pulmonary vasoconstriction are the most likely explanations for the mosaic pattern of lung attenuation. However, the relative contribution of these two mechanisms have not been formally evaluated in obstructive airway disease.
CT densitometry of the lungs is reproducible and accurate and has been applied to the investigation of different lung pathologies (19, 20). However, lung density is variable because of gravity dependence and effects of respiration (38). A functional CT study of change in lung density after bronchoprovocation in asthmatic subjects provides an ideal model for evaluating the mechanism of the mosaic pattern of lung attenuation because it has been shown to be reversible in acutely induced airway obstruction (10). Thus it is possible to manipulate rapidly reversible hypoxic vasoconstriction by administering oxygen and to control for changes in lung inflation so as to investigate the relative contributions of both factors. We therefore evaluated density change in hypodense regions in relation to increasing oxygen dosage, with and without correction for global lung density that reflects global lung inflation.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Subjects.
Twenty-two adult asthmatic volunteers were recruited through the
Clinical Studies Unit, National Heart and Lung Institute, Imperial
College, at Royal Brompton Hospital. Approval for the study was given
by the local Ethics Committee. The volunteers were asymptomatic and on
no medication on the day of the study and gave informed consent.
Subjects were randomized into three groups after a methacholine
challenge: group A, breathing room air
without a mask or any other device (n = 8); group B, breathing room air
supplemented by oxygen at a flow rate of 5 l/min via nasal cannulas
(n = 8); and group
C, breathing a high concentration of oxygen via face
masks at a flow rate of 12 l/min (n = 6). The oxygen was administered to the subjects sitting in an upright position for 20 min after the first CT and in a supine position during
the second CT for a further 10 min (Fig.
1). The additional oxygen was temporarily
interrupted to measure forced expiratory volume in 1 s
(FEV1) immediately before the
second CT. Median age, age range, gender, and smoking history for the
three groups were as follows: group A:
27.5 yr, 22-35 yr, 7 men, 1 woman, all nonsmokers;
group B: 27 yr, 23-44 yr, 8 men,
1 smoker (2 pack · yr); and group
C: 32 yr, 31-42 yr, 5 men, 1 woman, all
nonsmokers, respectively.
|
Bronchial challenge.
A standard bronchial challenge was performed with methacholine (Sigma
Chemical, Poole, Dorset, UK) administered via a nebulizer (Dosimeter
MB3, Mefar, Bovezzo, Italy) in increasing doubling concentrations,
starting at 0.0625 mg/ml. The subjects were asked to avoid physical
exercise and bronchodilator drugs for 24 h before the challenge. A
first baseline assessment of FEV1
was performed with a spirometer (Vitalograph, Buckingham, UK) before
and after the subject had inhaled five breaths of saline-control. The
decrease in FEV1 during the
methacholine was monitored after each dose of methacholine until a
>40% fall in FEV1 from the
postsaline baseline value was achieved. In one patient in group
C, the challenge had to be limited to a fall in
FEV1 of only >30% because of a low prechallenge FEV1. The log
concentration of methacholine, measured in mg/ml, needed to cause a
20% decrease in FEV1 was calculated by linear
interpolation of the log dose-response curve. Before the subjects left
the department after the second CT examination, their
FEV1 had to have returned to
within 5% of the presaline baseline. A short acting
-agonist was
administered by a metered dose inhaler if necessary.
CT. Images were obtained with an electron-beam CT (Imatron, San Francisco, CA) with a scan-acquisition time of 200 ms. Scanning and reconstruction parameters were 130 kV, 630 mA, 30-cm field-of-view, 1.5-mm section thickness, 512 × 512 matrix size, and high-spatial-frequency reconstruction algorithm. The first CT was performed immediately after the bronchial challenge and consisted of three adjacent sections obtained at the level of the carina (upper zone) and 4 cm above the dome of the right hemidiaphragm (lower zone). The images were obtained at suspended full inspiration, with a 5-mm gap between the three sections obtained at each level. The second CT followed 20 min later (Fig. 1). To obtain comparable sections for the second examination, volume aquisitions centered around the central section of the initial scan in each of the two zones were performed (n = 7 slices; covered volume 10.5 mm) at suspended full inspiration. Each CT examination was performed within ~10 min.
Image analysis.
Matching sections of the first and the second CT scans were obtained by
comparing anatomic landmarks, and each lung was considered separately.
The selected image sets were transferred to a workstation (Sun
Microsystems, Mountain View, CA). Postprocessing was applied to outline
the lungs and remove pulmonary vessels and bronchial walls. This was
achieved by thresholding the vessels and bronchi at a value of
400 Hounsfield units (HU). To minimize the effects of partial
volume averaging, mathematical morphology tools were applied to remove
pixels immediately adjacent to thresholded areas (Fig.
2). The lungs were divided into anterior,
middle, and posterior regions, each comprising a third of the
anterior-posterior diameter of the lung. In both the upper and the
lower zones, a set of six density measurements was obtained for each
lung and each region by using a circular region of interest (ROI) with
a diameter of 10 pixels (6 mm). The ROIs were placed on the images of
the first CT in areas judged to be of decreased attenuation
(ROIhypodense) and areas of
increased attenuation (ROIdense)
of the mosaic pattern (Fig. 2). For the measurements on the second CT
images, the ROIs were placed at near-identical sites according to
anatomic landmarks. The window setting for selecting the ROIs was
800/1,000 (window level/width). The percent density differences
[(ROICT2
ROICT1)/ROICT1] were calculated for ROIhypodense
and ROIdense.
|
histogramCT1)/histogramCT1] were calculated.
The regional density changes in
ROIhypodense were corrected for
global density changes by subtracting the density alterations measured
by histogrammean to separate
regional from global density changes. This additional parameter was
abbreviated as
ROIhypodense-corrected, and its
calculation was based on the average density change in all
ROIhypodense of both lungs in each
zone separately.
To take account of the influence of the lung volume on the results of
the density measurements, cross-sectional areas of the lungs were
calculated on the first and the second CT scans. Postprocessed images
were used to assess the cross-sectional area of the lung tissue
excluding pulmonary vessels.
Statistical analysis. For statistical evaluations, nonparametric tests of significance for unpaired data (Mann-Whitney U-test, Kruskal-Wallis test), nonparametric tests of correlation (Spearman rank correlation coefficient), and bivariate analysis were used. Bivariate linear regression models (23) were constructed to evaluate whether oxygen doses and changes in cross-sectional area were independent determinants of CT density increases. The validity of the assumptions of linear regression were confirmed by testing for omitted variables (none identified, P > 0.20 for all analyses) and heteroscedasticity (P > 0.20). P < 0.05 was considered statistically significant. All analyses used percent change from baseline.
| |
RESULTS |
|---|
|
|
|---|
The median fall in FEV1 from the
postsaline baseline was 48.1, 45.02, and 49.42% in
groups A,
B, and
C, respectively (Table 1). In all subjects,
FEV1 spontaneously recovered after
the challenge. The median percentage of
FEV1 recovery was comparable in
all groups (Table 1). The recovery of FEV1 was not
related to density changes in
ROIhypodense
(RS = 0.07).
|
The increase in mean density in
ROIhypodense on serial CT was
greatest in group C and greater in
group B than in group
A (P = 0.04) (Fig.
3); this finding remained significant in lower zone ROIhypodense
(P = 0.03) (Fig. 4,
Table 2) but not in upper zone ROIhypodense
(P = 0.29). As shown in Figs. 3 and 4,
these trends were almost entirely due to increases between
groups A and
B, with little further increase in
group C; on the basis of this finding,
data from groups B and
C were combined in subsequent bivariate analyses. In the lower zone,
histogrammean increased most in
group C and more in
group B than in group
A, with the difference between groups
A and C reaching
statistical significance (P = 0.03)
(Table 3). Correspondingly, histograms of the frequency distribution of lung attenuation in the lower zone were shifted to the
right for groups B and
C, but there was no overt density increase in group A (Fig.
5, A-C).
|
|
|
|
|
When the density change peculiar to ROIhypodense was calculated (ROIhypodense-corrected), it was higher in group B than in group A (P < 0.002), and in group C than in group A (P < 0.02). In the lower zone, density increased in group C and more in group B than in group A (P < 0.005); upper zone changes were not statistically significant. By contrast, density change in ROIdense did not differ significantly among the three groups.
The cross-sectional area of the lung decreased most in
group C (upper zone: median
13%; range
15.40 to
0.89%; lower zone: median
13.4%; range
16.66 to 1.95%), and more in
group B (upper zone: median
4.2%; range
13.28 to 3.36%; lower zone: median
1.8%; range
20.66 to 40.93%) than in
group A (upper zone: 2.2%; range
23.94 to 13.88%; lower zone: median 2.7%; range
19.25 to 35.08%). Change in cross-sectional area correlated strongly with
change in density in ROIhypodense
(combined zones
RS =
0.71, P < 0.0005) (Fig. 6)
(upper zone RS =
0.61,
P < 0.005; lower zone
RS =
0.77,
P < 0.00005) (Fig.
7), with change in
histogrammean (combined zones
RS =
0.70,
P < 0.0005; upper zone
RS =
0.58, P < 0.005; lower zone
RS =
0.89,
P < 0.00005) and with change in
density in ROIdense (lower zone
RS =
0.76,
P = 0.0005).
|
|
On bivariate analysis, density increase in ROIhypodense, if both upper and lower zone were taken together, was positively related to decrease in cross-sectional area (P < 0.0005) and to increasing inspired oxygen dosage (P = 0.01), equation R2 = 0.71. Density increase in lower zone ROIhypodense was also positively and independently related to both decrease in cross-sectional area (P < 0.005) and increasing inspired oxygen dosage (P < 0.005), equation R2 = 0.77. Furthermore, increasing oxygen concentration was the sole determinant of density increase in ROIhypodense-corrected both in upper and lower zone taken together (P = 0.02) and in lower zone regarded separately (P < 0.001).
| |
DISCUSSION |
|---|
|
|
|---|
High-resolution CT has recently been used to elucidate several pathophysiological phenomena in the lungs (4, 17, 18, 24, 42), particularly the response of the macroscopic airways to various bronchoactive stimuli (12, 12a, 29). The striking heterogeneity of the constrictive airway reaction has been attributed to local mechanisms in the airways and is largely independent of the route of administration of histamine (5). The lung density alterations visible on CT images after experimentally induced bronchoconstriction correspond to the mosaic pattern of lung attenuation observable in other airway diseases, such as acute spontaneous asthma, constrictive bronchiolitis, bronchiectasis, and hypersensitivity pneumonitis (14-16, 26). There appears to be a good correlation between recovery of FEV1 and regression of the mosaic pattern on expiratory CT images after drug-induced bronchodilation; the underlying cause of the decreased attenuation on expiratory CT images has been ascribed to air trapping (10), implying that an increased residual volume at end expiration causes compression of alveolar capillaries and thus a reduction in perfusion, as well as an increased proportion of gas within each voxel. However, it has not been clear whether the same mosaic pattern on inspiratory CT images is due to hypoxic pulmonary vasoconstriction (41) or air trapping, causing mechanical pressure on blood vessels (36). The latter has been regarded as the predominant mechanism of the hypertransradiant lung caused by central airways obstruction (13).
We have shown that for all regional and global measurements, with the exception of ROIdense, a significant density increase occurs in subjects breathing oxygen. Confirmation of the effect of oxygen was provided by bivariate analysis, which showed an independent relationship to the density measurements in ROIhypodense. Furthermore, oxygen concentration was the sole determinant for ROIhypodense-corrected. Thus hypoxic pulmonary vasoconstriction contributes to the regional hypodense areas of the mosaic pattern of lung attenuation on inspiratory CT images.
In long-standing, irreversible airway disease, hypoxic vasoconstriction is likely to be fixed due to vascular remodeling (35); thus a model of induced acute airway obstruction is best suited to investigate the influence of hypoxic pulmonary vasoconstriction on the mosaic attenuation pattern because of its reversibility. Furthermore, in irreversible small airway disease caused by constrictive obliterative bronchiolitis, increased total lung capacity can cause a global decrease in lung density (16).
The effect of oxygen administration on hypoxic pulmonary vasoconstriction was most pronounced in the dependent parts of the lungs. This is in accordance with previous functional CT studies that have shown that, after a methacholine challenge, the attenuation shift toward lower density values is most marked in the dependent lung regions (12, 24, 27). The same applies to the attenuation decrease after a hypoxic challenge, which has been reported to be significant only in the middle and posterior parts of the lungs (18). In addition to this gradient effect, there was a greater density increase in the lower zones compared with the upper zones. It seems probable that this phenomenon also reflects the gravity-dependent increased perfusion of the more dependent lung: the greater vertical distance in the lower zones (in the recumbent position) results in relatively more perfusion and a potentially greater vasoconstrictor response to the methacholine-induced bronchoconstriction.
Because respiratory gating was not used in our study, a possible influence of different degrees of inspiration on the density measurements has to be considered, even with cooperative volunteers (19). Cross-sectional area of the lungs decreased during the second CT examination in subjects breathing oxygen via nasal cannulas; this was even more pronounced in subjects who were administered oxygen via face masks. This phenomenon was also reflected by the curves representing the frequency distribution of lung attenuation and affected predominantly the lower zone of the lungs (Fig. 5, A-C). The changes in cross-sectional area correlated with regional (ROIhypodense and ROIdense) and global (histogrammean) density alterations. However, because the density increase within hypoattenuating areas of the mosaic pattern was more pronounced than the overall shift of the histograms toward higher-density values, there was no correlation between the decrease in the cross-sectional area of the lungs and ROIhypodense-corrected. Therefore, the decrease in cross-sectional area had an independent effect on the global lung density measurements and on the hypoattenuating and dense areas of the mosaic pattern and was distinct from the effect of the oxygen administration. The predominance of this effect in the lower lung zones is in keeping with the previously reported observation that changes in lung volume affect the density of the lung in dependent regions more than in nondependent parts of the lungs (38).
In our study, the mode of administration of oxygen seemed to be related to the degree of decrease in cross-sectional area of the lungs. This might be explicable by the method of oxygen delivery causing an alteration in the breathing pattern or total lung capacity of the subjects. Although a significant increase in total lung capacity has been reported in acute spontaneous asthma, this does not occur in induced asthma attacks (3, 22, 30). Similar effects of oxygen in patients with chronic obstructive pulmonary disease have been described (6, 9, 37). These changes have been attributed to a decrease in the hypoxic drive, resulting in a decrease in minute ventilation, thus causing a delay of ventilatory muscle fatigue and an altered respiratory muscle recruitment pattern (6, 9, 37). Interactions between changes in the breathing pattern and the degree of inspiration might therefore be a further explanation.
A potential source of measurement error relates to the positioning of
the ROIs on the images of the first and second CTs. Exactly comparable
positioning was not possible because the ROIs could not be
automatically maintained between scans. The influence of major
pulmonary vessels on the density measurement within ROIs was minimized
by applying a threshold postprocessing, which eliminated pixels with
density values less than
400 HU and pixels immediately next to
them. Thus the image postprocessing allowed a greater choice for the
positioning of ROI measurements. The usefulness of an automatic ROI
maintenance program on nonpostprocessed images is limited because
larger anatomic landmarks (pulmonary vessels) are relatively fixed,
whereas smaller vessels are more liable to appear inconstantly in ROIs
on serial CT images (18, 24).
Oxygen administration is a potent method of reversing hypoxia in acute asthmatic attacks. The intra-alveolar concentration of oxygen achieved by the methods of oxygen administration used in this study is unknown because there is no noninvasive technique for assessing the regional alveolar oxygen concentration. The oxygen concentration supplied by low-flow devices, such as nasal prongs, is variable and depends mainly on minute ventilation. By applying an oxygen flow rate of 5 l/min through nasal prongs, a 10-15% increase in the oxygen concentration in the inhaled air is usually assumed (25). With simple oxygen masks without rebreathing bags or entrainment ports, oxygen concentrations as high as 55-65% can be achieved at a flow rate of 12 l/min (25). Hypoventilated areas distal to severely constricted bronchi or bronchioles are usually supplied by collateral ventilation. An increase in the end-expiratory volume has been shown to reduce the resistance of the collateral ventilatory system in normal humans (8). After methacholine challenge, a reverse effect has been described in dogs: methacholine causes constriction of the collateral pathways, but the time constant for the collateral ventilation does not change (34). The lack of a significant intrapulmonary shunt is a further indication of the efficacy of the collateral ventilation in acute asthma (32, 40). Given the duration and flow rates of the oxygen supply in the present study, and the effectiveness of the collateral ventilatory system, it seems reasonable to assume that sufficient intra-alveolar oxygen concentration was achieved even in severely bronchoconstricted regions of the lungs.
The basic mechanism of hypoxic pulmonary vasoconstriction has been studied in cats, and it is thought to be the key physiological mechanism for maintaining ventilation-perfusion homogeneity in underventilated parts of the lung to minimize arterial hypoxia (11). The hypoxic vasoconstrictive response occurs within 1-2 min and is reversible in <1 min after alveolar hypoxia has been relieved (28). Therefore, if a sufficient intra-alveolar oxygen concentration is achieved, the vascular response should be detectable almost immediately in induced acute airway obstruction.
In an earlier study, after an initial drop in FEV1 after methacholine, there was a plateau with a mean duration of 74.6 ± 53.7 (SD) min and a consecutive recovery phase of 56.7 ± 38.3 min (7). In our study, a plateau phase was not as obvious, possibly because of the relatively long intervals between FEV1 measurements. However, severe airflow obstruction was present at the end of the study protocol and, equally importantly, there was no significant difference in the recovery rate among the three groups. In addition, the recovery of FEV1 showed no correlation with the measurable density increase. This is in agreement with previous studies, in which discrepancies between FEV1 measurements and parameters of gas exchange and peripheral resistance in asthmatic subjects have been demonstrated (31, 39, 40). In these studies, recovery of gas exchange did not parallel recovery of FEV1. Furthermore, the peripheral resistance remained elevated despite a return to normal FEV1 values after an acute asthmatic attack (31, 39). Thus the mosaic pattern of lung attenuation most likely reflects abnormalities of the smaller peripheral airways.
In summary, we have shown that hypoxic pulmonary vasoconstriction is a major determinant of the hypodense areas of the mosaic pattern of lung attenuation on CT in acute airway obstruction.
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to Professor Neil B. Pride for advice; to Jennifer McGrath and Sarah Aikman of the Clinical Studies Unit, National Heart and Lung Institute, Imperial College, who performed the methacholine challenges, for assistance; and to Wendy Jordan for supervising the CT scans.
| |
FOOTNOTES |
|---|
C. Gückel was supported by grants from the Karger Stiftung and the Freie Akademische Gesellschaft, Basel, Switzerland.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests: D. M. Hansell, Dept. of Radiology, Royal Brompton Hospital, Sydney St., London SW3 6NP, UK (E-mail: d.hansell{at}rbh.nthames.nhs.uk).
Received 3 February 1998; accepted in final form 6 November 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Bergin, C. J.,
C. Rios,
M. A. King,
E. Belezzuol,
J. Luna,
and
W. R. Auger.
Accuracy of high-resolution CT in identifying chronic pulmonary thrombembolic disease.
Am. J. Roentgenol.
166:
1371-1377,
1996
3.
Blackie, S. P.,
S. Al-Majed,
C. A. Staples,
C. Hilliam,
and
P. D. Paré.
Changes in total lung capacity during acute spontaneous asthma.
Am. Rev. Respir. Dis.
142:
79-83,
1990[Medline].
4.
Brown, R. H.,
C. J. Herold,
C. A. Hirshman,
E. A. Zerhouni,
and
W. Mitzner.
In vivo measurements of airway reactivity using high-resolution computed tomography.
Am. Rev. Respir. Dis.
144:
208-212,
1991[Medline].
5.
Brown, R. H.,
C. J. Herold,
C. A. Hirshman,
E. A. Zerhouni,
and
W. Mitzner.
Individual airway constrictor response heterogeneity to histamine assessed by high-resolution computed tomography.
J. Appl. Physiol.
74:
2615-2620,
1993
6.
Bye, P. T. P.,
S. A. Esau,
R. D. Levy,
R. J. Shiner,
P. T. Macklem,
J. G. Martin,
and
R. L. Pardy.
Ventilatory muscle function during exercise in air and oxygen in patients with chronic air-flow limitation.
Am. Rev. Respir. Dis.
132:
236-240,
1985[Medline].
7.
Cartier, A.,
J. L. Malo,
P. Bégin,
M. Sestier,
and
R. R. Martin.
Time course of the bronchoconstriction induced by inhaled histamine and methacholine.
J. Appl. Physiol.
54:
821-826,
1983
8.
Cormier, Y.,
M. Laviolette,
L. Atton,
and
F. Sériès.
Influence of lung volume on collateral resistance in normal man.
Respir. Physiol.
83:
179-188,
1991[Medline].
9.
Criner, G. J.,
and
B. R. Celli.
Ventilatory muscle recruitment on exercise with O2 in obstructed patients with mild hypoxemia.
J. Appl. Physiol.
63:
195-200,
1987
10.
DeSantis, M.,
C. Leonetti,
L. L. Ciarpaglini,
F. M. Pau,
P. Pavone,
and
G. Pedicelli.
Reversal of air trapping as shown at expiratory high-resolution CT after drug-induced bronchodilatation: CT evaluation of pharmacologic effects in asthma (Abstract).
Radiology
197:
438,
1995.
11.
von Euler, U. S.,
and
G. Liljestrand.
Observations on the pulmonary arterial blood pressure in the cat.
Acta Physiol. Scand.
12:
301-320,
1946.
12.
Goldin, J. G.,
D. R. Aberle,
P. M. Matthias,
B. Dauphinee,
M. F. McNitt-Gray,
T. D. Johnson,
E. B. Kleerup,
and
D. P. Tashkin.
Airway hyperreactivity (AHR) using helical HRCT following methacholine bronchoprovocation in asthmatics (Abstract).
Am. Rev. Respir. Dis.
151:
A673,
1995.
12a.
Goldin, J. G.,
M. F. McNitt-Gray,
S. M. Sorenson,
T. D. Johnson,
B. Dauphinee,
E. C. Kleerup,
D. P. Tashkin,
and
D. R. Aberle.
Airway hyperreactivity: assessment with helical thin-section CT.
Radiology
208:
321-329,
1998
13.
Grainger, R. G.
The pulmonary circulation: the radiology of adaptation.
Clin. Radiol.
36:
103-116,
1985[Medline].
14.
Hansell, D. M.,
A. U. Wells,
M. B. Rubens,
and
P. J. Cole.
Bronchiectasis: functional significance of areas of decreased attenuation at expiratory CT.
Radiology
193:
369-374,
1994
15.
Hansell, D. M.,
A. U. Wells,
S. P. G. Padley,
and
N. L. Müller.
Hypersensitivity pneumonitis: correlation of individual CT patterns with functional abnormalities.
Radiology
199:
123-128,
1996
16.
Hansell, D. M.,
M. B. Rubens,
S. P. G. Padley,
and
A. U. Wells.
Obliterative bronchiolitis: individual CT signs of small airway disease and functional correlation.
Radiology
203:
721-726,
1997
17.
Herold, C. J.,
R. H. Brown,
W. Mitzner,
J. M. Links,
C. A. Hirshman,
and
E. A. Zerhouni.
Assessment of pulmonary airway reactivity with high-resolution CT.
Radiology
181:
369-374,
1991
18.
Herold, C. J.,
R. C. Wetzel,
J. L. Robotham,
S. M. Herold,
and
E. A. Zerhouni.
Acute effects of increased intravascular volume and hypoxia on the pulmonary circulation: assessment with high-resolution CT.
Radiology
183:
655-662,
1992
19.
Kalender, W. A.,
H. Fichte,
W. Bautz,
and
M. Skalej.
Semiautomatic evaluation procedures for quantitative CT of the lung.
J. Comput. Assist. Tomogr.
15:
248-255,
1991[Medline].
20.
Kemerink, G. J.,
R. J. S. Lamers,
G. R. P. Thelissen,
and
J. M. A. van Engelshoven.
CT densitometry of the lungs: scanner performance.
J. Comput. Assist. Tomogr.
20:
24-33,
1996[Medline].
21.
King, M. A.,
C. J. Bergin,
D. W. C. Yeung,
E. E. Belezzouli,
L. K. Olson,
W. L. Ashburn,
W. R. Auger,
and
K. M. Moser.
Chronic pulmonary thromboembolism: detection of regional hypoperfusion with CT.
Radiology
191:
359-363,
1994
22.
Kirby, J. G.,
E. F. Juniper,
F. E. Hargreave,
and
N. Zamel.
Total lung capacity does not change during methacholine-stimulated airway narrowing.
J. Appl. Physiol.
61:
2144-2147,
1986
23.
Kleinbaum, D. G.,
L. L. Kupper,
and
R. Muller.
Applied Regression Analysis and Other Multivariate Methods. Boston, MA: Kent, 1988.
24.
Kramer, S. S.,
and
E. A. Hoffman.
Physiologic imaging of the lung with volumetric high-resolution CT.
J. Thorac. Imaging
10:
280-290,
1995[Medline].
25.
Levitzky, M. G.,
J. M. Cairo,
and
S. M. Hall.
Introduction to Respiratory Care. Philadelphia, PA: Saunders, 1990.
26.
Lynch, D. A.,
J. D. Newell,
B. A. Tschomper,
T. M. Cink,
L. S. Newman,
and
R. Bethel.
Uncomplicated asthma in adults: comparison of CT appearance of the lungs in asthmatics and healthy subjects.
Radiology
188:
829-833,
1993
27.
McNitt-Gray, M. F.,
J. G. Goldin,
T. D. Johnson,
D. P. Tashkin,
and
D. R. Aberle.
Development and testing of image-postprocessing methods for the quantitative assessment of airway hyperresponsiveness from high-resolution CT images.
J. Comput. Assist. Tomogr.
21:
939-947,
1997[Medline].
28.
Naeije, R.
Pulmonary vascular function.
In: Pulmonary Circulation, edited by A. J. Peacock. London: Chapman & Hall, 1996.
29.
Paganin, F.,
A. M. Vignola,
E. Senéterre,
J. M. Bruel,
P. Chanez,
and
J. Bousquet.
Heterogeneity of airways obstruction in asthmatic patients using high-resolution computed tomography.
Chest
107:
145S-146S,
1995
30.
Permutt, S.,
H. E. Fessler,
R. G. Brower,
and
E. Kosnik.
Breathlessness in acute asthma.
In: Breathlessness, edited by N. L. Jones,
and K. J. Killian. Hamilton, Ontario: Boehringer, 1992.
31.
Roca, J.,
L. Ramis,
R. Rodriguez-Roisin,
E. Ballester,
J. M. Montserrat,
and
P. D. Wagner.
Serial relationship between ventilation-perfusion inequality and spirometry in acute severe asthma requiring hospitalization.
Am. Rev. Respir. Dis.
137:
1055-1061,
1988[Medline].
32.
Rodriguez-Roisin, R.,
E. Ballester,
J. Roca,
A. Torres,
and
P. D. Wagner.
Mechanisms of hypoxemia in patients with status asthmaticus requiring mechanical ventilation.
Am. Rev. Respir. Dis.
139:
732-739,
1989[Medline].
33.
Sherrick, A. D.,
S. J. Swensen,
and
T. E. Hartman.
Mosaic patterns of lung attenuation on CT scans: frequency among patients with pulmonary artery hypertension of different causes.
Am. J. Roentgenol.
169:
79-82,
1997
34.
Smith, L. J.,
C. R. Inners,
P. B. Terry,
H. A. Menkes,
and
R. J. Traystman.
Effects of methacholine and hypocapnia on airways and collateral ventilation in dogs.
J. Appl. Physiol.
46:
966-972,
1979
35.
Smith, P.
Ultrastructure of the lung in chronic hypoxia.
Thorax
49:
27-32,
1994.
36.
Stern, E. J.,
N. L. Müller,
S. J. Swensen,
and
T. E. Hartman.
The mosaic pattern of lung attenuation: etiologies and terminology.
J. Thorac. Imaging
10:
294-297,
1995[Medline].
37.
Swinburn, C. R.,
H. Mould,
T. N. Stone,
P. A. Corris,
and
G. J. Gibson.
Symptomatic benefit of supplemental oxygen in hypoxic patients with chronic lung disease.
Am. Rev. Respir. Dis.
143:
913-915,
1991[Medline].
38.
Verschakelen, J. A.,
L. van Fraeyenhoven,
G. Laureys,
M. Demedts,
and
A. L. Baert.
Differences in CT density between dependent and nondependent portions of the lungs: influence of lung volume.
Am. J. Roentgenol.
161:
713-717,
1993
39.
Wagner, E. M.,
M. C. Liu,
G. G. Weinmann,
S. Permutt,
and
E. R. Bleecker.
Peripheral lung resistance in normal and asthmatic subjects.
Am. Rev. Respir. Dis.
141:
584-588,
1990[Medline].
40.
Wagner, P. D.,
and
R. Rodriguez-Roisin.
Clinical advances in pulmonary gas exchange.
Am. Rev. Respir. Dis.
143:
883-888,
1991[Medline].
41.
Webb, W. R.,
N. L. Müller,
and
D. P. Naidich.
HRCT findings of lung disease.
In: High-Resolution CT of the Lung (2nd ed.), edited by W. R. Webb,
N. L. Müller,
and D. P. Naidich. Philadelphia, PA: Lippincott-Raven, 1996, p. 41-108.
42.
Wetzel, R. C.,
C. J. Herold,
E. A. Zerhouni,
and
J. L. Robotham.
Hypoxic bronchodilatation.
J. Appl. Physiol.
73:
1202-1206,
1992
43.
Worthy, S. A.,
N. L. Müller,
T. E. Hartman,
S. J. Swensen,
S. P. G. Padley,
and
D. M. Hansell.
Mosaic attenuation pattern on thin-section CT of the lung: differentiation among infiltrative lung, airway, and vascular diseases as a cause.
Radiology
205:
465-470,
1997
This article has been cited by other articles:
![]() |
D. A. Kaminsky, C. G. Irvin, L. K. A. Lundblad, J. Thompson-Figueroa, J. Klein, M. J. Sullivan, F. Flynn, S. Lang, L. Bourassa, S. Burns, et al. Heterogeneity of bronchoconstriction does not distinguish mild asthmatic subjects from healthy controls when supine J Appl Physiol, January 1, 2008; 104(1): 10 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Suga, Y. Kawakami, H. Iwanaga, O. Tokuda, and N. Matsunaga Automated Breath-Hold Perfusion SPECT/CT Fusion Images of the Lungs Am. J. Roentgenol., August 1, 2007; 189(2): 455 - 463. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Knollmann, R. Ewert, T. Wundrich, R. Hetzer, and R. Felix Bronchiolitis Obliterans Syndrome in Lung Transplant Recipients: Use of Spirometrically Gated CT Radiology, December 1, 2002; 225(3): 655 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.M. Hansell Small airways diseases: detection and insights with computed tomography Eur. Respir. J., June 1, 2001; 17(6): 1294 - 1313. [Abstract] [Full Text] [PDF] |
||||
![]() |
H R Roberts, A U Wells, D G Milne, M B Rubens, J Kolbe, P J Cole, and D M Hansell Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests Thorax, March 1, 2000; 55(3): 198 - 204. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |